BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 20378318)

  • 1. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.
    Panossian A; Wikman G; Sarris J
    Phytomedicine; 2010 Jun; 17(7):481-93. PubMed ID: 20378318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
    Olsson EM; von Schéele B; Panossian AG
    Planta Med; 2009 Feb; 75(2):105-12. PubMed ID: 19016404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches of Rhodiola kirilowii and Rhodiola rosea field cultivation in Poland and their potential health benefits.
    Grech-Baran M; Sykłowska-Baranek K; Pietrosiuk A
    Ann Agric Environ Med; 2015; 22(2):281-5. PubMed ID: 26094524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice.
    Perfumi M; Mattioli L
    Phytother Res; 2007 Jan; 21(1):37-43. PubMed ID: 17072830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats.
    Mattioli L; Funari C; Perfumi M
    J Psychopharmacol; 2009 Mar; 23(2):130-42. PubMed ID: 18515456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
    Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea.
    Ali Z; Fronczek FR; Khan IA
    Planta Med; 2008 Feb; 74(2):178-81. PubMed ID: 18240104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on Roseroot (Rhodiola rosea) studies.
    Blomkvist J; Taube A; Larhammar D
    Planta Med; 2009 Sep; 75(11):1187-90. PubMed ID: 19468971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
    Mannucci C; Navarra M; Calzavara E; Caputi AP; Calapai G
    Phytomedicine; 2012 Sep; 19(12):1117-24. PubMed ID: 22921986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials.
    Hung SK; Perry R; Ernst E
    Phytomedicine; 2011 Feb; 18(4):235-44. PubMed ID: 21036578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats.
    Chen QG; Zeng YS; Qu ZQ; Tang JY; Qin YJ; Chung P; Wong R; Hägg U
    Phytomedicine; 2009 Sep; 16(9):830-8. PubMed ID: 19403286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodiola rosea: a possible plant adaptogen.
    Kelly GS
    Altern Med Rev; 2001 Jun; 6(3):293-302. PubMed ID: 11410073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H
    Phytother Res; 2005 Oct; 19(10):819-38. PubMed ID: 16261511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea.
    Cayer C; Ahmed F; Filion V; Saleem A; Cuerrier A; Allard M; Rochefort G; Merali Z; Arnason JT
    Planta Med; 2013 Oct; 79(15):1385-91. PubMed ID: 23975866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative phytochemical characterization of three Rhodiola species.
    Yousef GG; Grace MH; Cheng DM; Belolipov IV; Raskin I; Lila MA
    Phytochemistry; 2006 Nov; 67(21):2380-91. PubMed ID: 16956631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue.
    Ross SM
    Holist Nurs Pract; 2014; 28(2):149-54. PubMed ID: 24503750
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhodiola rosea (SHR-5), Part 2: A standardized extract of Rhodiola rosea is shown to be effective in the treatment of mild to moderate depression.
    Ross SM
    Holist Nurs Pract; 2014; 28(3):217-21. PubMed ID: 24722617
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rhodiola rosea and its neuropsychotropic effects].
    Juřica J; Koupá T
    Ceska Slov Farm; 2016; 65(3):87-93. PubMed ID: 27854435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study.
    Edwards D; Heufelder A; Zimmermann A
    Phytother Res; 2012 Aug; 26(8):1220-5. PubMed ID: 22228617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibition by Rhodiola rosea L. roots.
    van Diermen D; Marston A; Bravo J; Reist M; Carrupt PA; Hostettmann K
    J Ethnopharmacol; 2009 Mar; 122(2):397-401. PubMed ID: 19168123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.